
Nancy Bitar
Examiner (ID: 18935, Phone: (571)270-1041 , Office: P/2669 )
| Most Active Art Unit | 2664 |
| Art Unit(s) | 2624, 2669, 2664 |
| Total Applications | 1257 |
| Issued Applications | 1017 |
| Pending Applications | 63 |
| Abandoned Applications | 197 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 5154876
[patent_doc_number] => 20070037759
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-02-15
[patent_title] => 'Mammalian retrotransposable elements'
[patent_app_type] => utility
[patent_app_number] => 10/544458
[patent_app_country] => US
[patent_app_date] => 2004-02-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 5896
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0037/20070037759.pdf
[firstpage_image] =>[orig_patent_app_number] => 10544458
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/544458 | Mammalian retrotransposable elements | Feb 5, 2004 | Abandoned |
Array
(
[id] => 5637420
[patent_doc_number] => 20060068393
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-03-30
[patent_title] => 'Mevalonate kinase as a target for fungicides'
[patent_app_type] => utility
[patent_app_number] => 10/544657
[patent_app_country] => US
[patent_app_date] => 2004-01-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 15941
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0068/20060068393.pdf
[firstpage_image] =>[orig_patent_app_number] => 10544657
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/544657 | Mevalonate kinase as a target for fungicides | Jan 27, 2004 | Abandoned |
Array
(
[id] => 6917691
[patent_doc_number] => 20050095252
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-05-05
[patent_title] => 'Promoter for high-throughput screening for inhibitors against Mycobacteria under low carbon conditions'
[patent_app_type] => utility
[patent_app_number] => 10/764553
[patent_app_country] => US
[patent_app_date] => 2004-01-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 6114
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0095/20050095252.pdf
[firstpage_image] =>[orig_patent_app_number] => 10764553
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/764553 | Promoter for high-throughput screening for inhibitors against Mycobacteria under low carbon conditions | Jan 26, 2004 | Issued |
Array
(
[id] => 7195715
[patent_doc_number] => 20050164209
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-07-28
[patent_title] => 'Hepatocyte free uptake assays'
[patent_app_type] => utility
[patent_app_number] => 10/763367
[patent_app_country] => US
[patent_app_date] => 2004-01-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9518
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0164/20050164209.pdf
[firstpage_image] =>[orig_patent_app_number] => 10763367
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/763367 | Hepatocyte free uptake assays | Jan 22, 2004 | Abandoned |
Array
(
[id] => 5148678
[patent_doc_number] => 20070048737
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-03-01
[patent_title] => 'Calcium phosphate ceramics and particles for in vivo and in vitro transfection'
[patent_app_type] => utility
[patent_app_number] => 10/540854
[patent_app_country] => US
[patent_app_date] => 2003-12-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5091
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0048/20070048737.pdf
[firstpage_image] =>[orig_patent_app_number] => 10540854
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/540854 | Calcium phosphate ceramics and particles for in vivo and in vitro transfection | Dec 23, 2003 | Abandoned |
Array
(
[id] => 5892367
[patent_doc_number] => 20060277628
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-12-07
[patent_title] => 'Artificial promoter for the expression of dna sequences in vegetal cells'
[patent_app_type] => utility
[patent_app_number] => 10/539476
[patent_app_country] => US
[patent_app_date] => 2003-12-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 9029
[patent_no_of_claims] => 72
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0277/20060277628.pdf
[firstpage_image] =>[orig_patent_app_number] => 10539476
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/539476 | Artificial promoter for the expression of dna sequences in vegetal cells | Dec 18, 2003 | Abandoned |
Array
(
[id] => 7083205
[patent_doc_number] => 20050048585
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-03-03
[patent_title] => 'Methods and compositions for modulating NF-AT transcription factor'
[patent_app_type] => utility
[patent_app_number] => 10/732894
[patent_app_country] => US
[patent_app_date] => 2003-12-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16954
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0048/20050048585.pdf
[firstpage_image] =>[orig_patent_app_number] => 10732894
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/732894 | Methods and compositions for modulating NF-AT transcription factor | Dec 9, 2003 | Abandoned |
Array
(
[id] => 5626107
[patent_doc_number] => 20060264612
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-11-23
[patent_title] => 'Optimised protein synthesis'
[patent_app_type] => utility
[patent_app_number] => 10/538405
[patent_app_country] => US
[patent_app_date] => 2003-12-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 16
[patent_no_of_words] => 6198
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0264/20060264612.pdf
[firstpage_image] =>[orig_patent_app_number] => 10538405
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/538405 | Optimised protein synthesis | Dec 8, 2003 | Abandoned |
Array
(
[id] => 5596230
[patent_doc_number] => 20060160147
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-07-20
[patent_title] => 'Recombinant cell line'
[patent_app_type] => utility
[patent_app_number] => 10/537647
[patent_app_country] => US
[patent_app_date] => 2003-12-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 13450
[patent_no_of_claims] => 41
[patent_no_of_ind_claims] => 10
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0160/20060160147.pdf
[firstpage_image] =>[orig_patent_app_number] => 10537647
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/537647 | Recombinant cell line | Dec 7, 2003 | Issued |
Array
(
[id] => 7234502
[patent_doc_number] => 20050079617
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-04-14
[patent_title] => 'Glucose transport mutants for production of biomaterial'
[patent_app_type] => utility
[patent_app_number] => 10/728337
[patent_app_country] => US
[patent_app_date] => 2003-12-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 19
[patent_figures_cnt] => 19
[patent_no_of_words] => 20202
[patent_no_of_claims] => 48
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0079/20050079617.pdf
[firstpage_image] =>[orig_patent_app_number] => 10728337
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/728337 | Glucose transport mutants for production of biomaterial | Dec 2, 2003 | Abandoned |
Array
(
[id] => 10870116
[patent_doc_number] => 08895310
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-11-25
[patent_title] => 'L-rhamnose-inducible expression systems'
[patent_app_type] => utility
[patent_app_number] => 10/537075
[patent_app_country] => US
[patent_app_date] => 2003-11-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 12298
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 110
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 10537075
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/537075 | L-rhamnose-inducible expression systems | Nov 26, 2003 | Issued |
Array
(
[id] => 7149956
[patent_doc_number] => 20040171147
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-09-02
[patent_title] => 'Cytotherapeutics, cytotherapeutic units and methods for treatments using them'
[patent_app_type] => new
[patent_app_number] => 10/721144
[patent_app_country] => US
[patent_app_date] => 2003-11-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7322
[patent_no_of_claims] => 53
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 13
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0171/20040171147.pdf
[firstpage_image] =>[orig_patent_app_number] => 10721144
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/721144 | Cytotherapeutics, cytotherapeutic units and methods for treatments using them | Nov 24, 2003 | Abandoned |
Array
(
[id] => 11357580
[patent_doc_number] => 09534224
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-01-03
[patent_title] => 'Cis/trans riboregulators'
[patent_app_type] => utility
[patent_app_number] => 10/535128
[patent_app_country] => US
[patent_app_date] => 2003-11-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 26
[patent_no_of_words] => 27742
[patent_no_of_claims] => 43
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 55
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 10535128
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/535128 | Cis/trans riboregulators | Nov 13, 2003 | Issued |
Array
(
[id] => 7025531
[patent_doc_number] => 20050019925
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-01-27
[patent_title] => 'Intron fusion construct and method of using for selecting high-expressing production cell lines'
[patent_app_type] => utility
[patent_app_number] => 10/715270
[patent_app_country] => US
[patent_app_date] => 2003-11-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 43
[patent_figures_cnt] => 43
[patent_no_of_words] => 13055
[patent_no_of_claims] => 37
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0019/20050019925.pdf
[firstpage_image] =>[orig_patent_app_number] => 10715270
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/715270 | Intron fusion construct and method of using for selecting high-expressing production cell lines | Nov 13, 2003 | Abandoned |
Array
(
[id] => 122380
[patent_doc_number] => 07704687
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2010-04-27
[patent_title] => 'Digital karyotyping'
[patent_app_type] => utility
[patent_app_number] => 10/705874
[patent_app_country] => US
[patent_app_date] => 2003-11-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 8471
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 135
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/704/07704687.pdf
[firstpage_image] =>[orig_patent_app_number] => 10705874
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/705874 | Digital karyotyping | Nov 12, 2003 | Issued |
Array
(
[id] => 5873969
[patent_doc_number] => 20060166207
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-07-27
[patent_title] => 'Hsan II related gene and expression products and uses thereof'
[patent_app_type] => utility
[patent_app_number] => 10/534419
[patent_app_country] => US
[patent_app_date] => 2003-11-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 22
[patent_figures_cnt] => 22
[patent_no_of_words] => 14983
[patent_no_of_claims] => 55
[patent_no_of_ind_claims] => 12
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0166/20060166207.pdf
[firstpage_image] =>[orig_patent_app_number] => 10534419
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/534419 | Hsan II related gene and expression products and uses thereof | Nov 11, 2003 | Abandoned |
Array
(
[id] => 7428836
[patent_doc_number] => 20040161846
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-08-19
[patent_title] => 'Method of expression and agents identified thereby'
[patent_app_type] => new
[patent_app_number] => 10/432234
[patent_app_country] => US
[patent_app_date] => 2003-11-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 40
[patent_figures_cnt] => 40
[patent_no_of_words] => 29633
[patent_no_of_claims] => 79
[patent_no_of_ind_claims] => 39
[patent_words_short_claim] => 17
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0161/20040161846.pdf
[firstpage_image] =>[orig_patent_app_number] => 10432234
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/432234 | Method of expression and agents identified thereby | Nov 6, 2003 | Abandoned |
Array
(
[id] => 5922186
[patent_doc_number] => 20060240426
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-10-26
[patent_title] => 'Gene expression in biological conditions'
[patent_app_type] => utility
[patent_app_number] => 10/533547
[patent_app_country] => US
[patent_app_date] => 2003-11-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 81
[patent_figures_cnt] => 81
[patent_no_of_words] => 52711
[patent_no_of_claims] => 58
[patent_no_of_ind_claims] => 15
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0240/20060240426.pdf
[firstpage_image] =>[orig_patent_app_number] => 10533547
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/533547 | Gene expression in biological conditions | Nov 2, 2003 | Abandoned |
Array
(
[id] => 5720785
[patent_doc_number] => 20060073560
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-04-06
[patent_title] => 'Selective expression in filamentous fungi'
[patent_app_type] => utility
[patent_app_number] => 10/533361
[patent_app_country] => US
[patent_app_date] => 2003-10-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 5513
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0073/20060073560.pdf
[firstpage_image] =>[orig_patent_app_number] => 10533361
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/533361 | Selective expression in filamentous fungi | Oct 30, 2003 | Abandoned |
Array
(
[id] => 7310459
[patent_doc_number] => 20040142892
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-07-22
[patent_title] => 'Autogene nucleic acids encoding a secretable RNA polymerase'
[patent_app_type] => new
[patent_app_number] => 10/688299
[patent_app_country] => US
[patent_app_date] => 2003-10-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 24792
[patent_no_of_claims] => 40
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 19
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0142/20040142892.pdf
[firstpage_image] =>[orig_patent_app_number] => 10688299
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/688299 | Autogene nucleic acids encoding a secretable RNA polymerase | Oct 15, 2003 | Abandoned |